ID29468A - Komposisi farmasi yang stabil dalam bentuk liofil - Google Patents

Komposisi farmasi yang stabil dalam bentuk liofil

Info

Publication number
ID29468A
ID29468A IDW20010749A ID20010749A ID29468A ID 29468 A ID29468 A ID 29468A ID W20010749 A IDW20010749 A ID W20010749A ID 20010749 A ID20010749 A ID 20010749A ID 29468 A ID29468 A ID 29468A
Authority
ID
Indonesia
Prior art keywords
liofiles
stable
pharmaceutical composition
pharmaceutical
composition
Prior art date
Application number
IDW20010749A
Other languages
English (en)
Indonesian (id)
Inventor
Seiji Sawai
Akihiro Kasai
Kazumi Otomo
Original Assignee
Fujisawa Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=16210881&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ID29468(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Fujisawa Pharmaceutical Co filed Critical Fujisawa Pharmaceutical Co
Publication of ID29468A publication Critical patent/ID29468A/id

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/08—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis for Pneumocystis carinii
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Pulmonology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IDW20010749A 1999-07-01 2000-06-29 Komposisi farmasi yang stabil dalam bentuk liofil ID29468A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP18771399 1999-07-01

Publications (1)

Publication Number Publication Date
ID29468A true ID29468A (id) 2001-08-30

Family

ID=16210881

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW20010749A ID29468A (id) 1999-07-01 2000-06-29 Komposisi farmasi yang stabil dalam bentuk liofil

Country Status (28)

Country Link
US (2) US6774104B1 (de)
EP (1) EP1107777B1 (de)
JP (2) JP3381722B2 (de)
KR (1) KR100454784B1 (de)
CN (2) CN100352495C (de)
AR (1) AR024634A1 (de)
AT (1) ATE280583T1 (de)
AU (1) AU752265B2 (de)
BR (2) BR0006823A (de)
CA (1) CA2341568C (de)
CZ (1) CZ295720B6 (de)
DE (1) DE60015279T2 (de)
ES (1) ES2225161T3 (de)
HK (2) HK1040057B (de)
HU (1) HU229089B1 (de)
ID (1) ID29468A (de)
IL (2) IL141455A0 (de)
MX (1) MXPA01000601A (de)
NO (1) NO330353B1 (de)
NZ (1) NZ510290A (de)
OA (1) OA11601A (de)
PL (1) PL200141B1 (de)
PT (1) PT1107777E (de)
RU (1) RU2251411C2 (de)
TR (1) TR200100609T1 (de)
TW (1) TWI233805B (de)
WO (1) WO2001002002A1 (de)
ZA (1) ZA200101589B (de)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI233805B (en) * 1999-07-01 2005-06-11 Fujisawa Pharmaceutical Co Stabilized pharmaceutical composition in lyophilized form as antifungal agent
ITMI20021040A1 (it) * 2002-05-16 2003-11-17 Novuspharma Spa Composizioni farmaceutiche iniettabili di un derivato antracenedionico ad attivita' antitumorale
JP3631748B2 (ja) 2002-07-31 2005-03-23 千寿製薬株式会社 水性液剤および光安定化された水性液剤
US8877168B1 (en) 2002-07-31 2014-11-04 Senju Pharmaceuticals Co., Ltd. Aqueous liquid preparations and light-stabilized aqueous liquid preparations
MXPA05005338A (es) * 2002-11-18 2005-12-14 Vicuron Pharm Inc Metodos para administrar dalbavancin para el tratamiento de infecciones bacterianas.
US7119061B2 (en) * 2002-11-18 2006-10-10 Vicuron Pharmaceuticals, Inc. Dalbavancin compositions for treatment of bacterial infections
US20060074014A1 (en) * 2002-11-18 2006-04-06 Vicuron Pharmaceuticals Inc. Dalbavancin compositions for treatment of bacterial infections
EP1721610B1 (de) 2004-03-04 2009-05-13 Eisai R&D Management Co., Ltd. Zusammensetzung mit benzamidin-derivat und verfahren zur stabilisierung von benzamidin-derivat
EP1751150A2 (de) * 2004-05-19 2007-02-14 Neurosearch A/S Neue azabicyclische arylderivate
CN101107013A (zh) * 2004-11-22 2008-01-16 阿纳迪斯有限公司 生物活性组合物
KR101307999B1 (ko) * 2004-12-01 2013-09-12 니폰 조키 세야쿠 가부시키가이샤 건조물 및 그 제조방법
WO2007010995A1 (ja) * 2005-07-20 2007-01-25 Kyowa Medex Co., Ltd. 生体試料中のペプチドの安定化方法
CN1962852B (zh) * 2006-11-27 2011-11-09 西北农林科技大学 红景天多糖在制备抗冻剂中的新用途及其产品和制备方法
CN102614491B (zh) * 2011-01-31 2014-04-16 上海天伟生物制药有限公司 一种含有棘白菌素类抗真菌剂米卡芬净的药用组合物及其制备方法和用途
CN102614492B (zh) * 2011-01-31 2013-12-11 上海天伟生物制药有限公司 一种含有棘白菌素类抗真菌剂米卡芬净的液体药用组合物
ES2651389T3 (es) * 2012-05-22 2018-01-26 Paion Uk Limited Composiciones que comprenden benzodiazepinas de acción corta
US20140274996A1 (en) 2013-03-15 2014-09-18 Cubist Pharmaceuticals, Inc. Tazobactam and ceftolozane antibiotic compositions
US20140274994A1 (en) 2013-03-15 2014-09-18 Cubist Pharmaceuticals, Inc. Stabilizing ceftolozane
US9872906B2 (en) 2013-03-15 2018-01-23 Merck Sharp & Dohme Corp. Ceftolozane antibiotic compositions
CN103330933B (zh) * 2013-04-26 2015-08-05 江苏豪森药业股份有限公司 含有米卡芬净或其盐的药物组合物
CN103330932B (zh) * 2013-04-26 2015-12-23 江苏豪森药业股份有限公司 一种米卡芬净或其盐的药物组合物
AU2014277568B2 (en) * 2013-06-05 2019-09-19 The University Of British Columbia Anti-fibrogenic compounds, methods and uses thereof
EP3043797B1 (de) 2013-09-09 2020-04-08 Merck Sharp & Dohme Corp. Behandlung von infektionen mit ceftolozan/tazobactam bei personen mit beeinträchtigter nierenfunktion
US20150094293A1 (en) 2013-09-27 2015-04-02 Calixa Therapeutics, Inc. Solid forms of ceftolozane
KR101611349B1 (ko) 2014-04-14 2016-04-12 신우철 안정성이 개선된 밀크씨슬 엑스의 제형
WO2015180681A1 (zh) * 2014-05-29 2015-12-03 上海天伟生物制药有限公司 一种环肽类化合物的组合物及其制备方法和用途
TWI691499B (zh) * 2014-12-05 2020-04-21 日商明治製菓藥業股份有限公司 二氮雜雙環辛烷衍生物之結晶及安定的凍結乾燥製劑的製造法
PL3240529T3 (pl) 2014-12-31 2022-05-02 Galenicum Health S.L.U. Stabilne kompozycje farmaceutyczne zawierające mykafunginę
PL3058958T3 (pl) 2015-02-23 2019-02-28 Selectchemie Ag Kompozycja anidulafunginy
FI3554474T3 (fi) 2016-12-16 2024-02-21 Baxter Int Mikafungiinikoostumuksia
WO2019005829A1 (en) * 2017-06-26 2019-01-03 Wayne State University METHODS AND COMPOSITIONS RELATING TO CANCER DEPENDENT ON HORMONE RECEPTORS
RU2666148C1 (ru) * 2017-10-05 2018-09-06 Общество с ограниченной ответственностью "Новые Антибиотики" Способ получения водорастворимой лиофилизированной формы соли бис(2-тио-4,6-диоксо-1,2,3,4,5,6-гексагидропиримидин-5-ил)-(4-нитрофенил)метана
EP3485873A1 (de) 2017-11-17 2019-05-22 Cadila Healthcare Limited Stabile pharmazeutische injizierbare zusammensetzungen von micafungin

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH03193735A (ja) 1989-12-22 1991-08-23 Shionogi & Co Ltd グリコペプチド系抗生物質の安定化組成物
JPH03240727A (ja) 1990-02-15 1991-10-28 Toyo Jozo Co Ltd ニューモシスチス・カリニ肺炎治療剤
IE990233A1 (en) * 1990-06-18 2000-11-15 Fujisawa Pharmaceutical Co New Polypeptide Compound and a Process for Preparation thereof
JP3193735B2 (ja) 1991-07-24 2001-07-30 株式会社リコー カラー画像形成装置の搬送装置
JPH0651641A (ja) 1992-07-30 1994-02-25 Olympus Optical Co Ltd 湿式現像装置
JPH06172204A (ja) * 1992-12-09 1994-06-21 Asahi Chem Ind Co Ltd アクレアシン類含有リポソーム製剤およびその製造法
JP3240727B2 (ja) 1993-02-25 2001-12-25 ソニー株式会社 偏平型陰極線管の画像歪補正装置
IL109615A (en) * 1993-05-17 2000-12-06 Fujisawa Pharmaceutical Co Cyclic polypeptide derivatives processes for the preparation thereof and pharmaceutical compositions containing the same
PT788511E (pt) 1994-10-07 2003-04-30 Fujisawa Pharmaceutical Co Hexapeptidos ciclicos com actividade antibiotica
GB9512854D0 (en) * 1995-06-23 1995-08-23 Wellcome Found Novel formulation
EP1854877B1 (de) * 1996-03-08 2012-02-08 Astellas Pharma Inc. Verfahren zur Deacylierung von zyklischen Lipopeptiden
AR006598A1 (es) * 1996-04-19 1999-09-08 Merck Sharp & Dohme "composiciones anti-fungosas, su uso en la manufactura de medicamentos y un procedimiento para su preparación"
JPH09301997A (ja) 1996-05-17 1997-11-25 Yamanouchi Pharmaceut Co Ltd 新規環状ペプチド系化合物
FR2755857B1 (fr) * 1996-11-19 1998-12-24 Rhone Poulenc Rorer Sa Compositions pharmaceutiques stabilisees, a base de quinupristine et de dalfopristine et leur preparation
AUPO371596A0 (en) * 1996-11-19 1996-12-12 Fujisawa Pharmaceutical Co., Ltd. New compound
AUPO381496A0 (en) * 1996-11-25 1996-12-19 Fujisawa Pharmaceutical Co., Ltd. New compound
JPH10279498A (ja) * 1997-04-07 1998-10-20 Nippon Shinyaku Co Ltd 慢性関節リウマチ治療剤
JP3544847B2 (ja) * 1998-01-16 2004-07-21 三菱電機株式会社 光学的情報再生方法および装置
JP2002538097A (ja) * 1999-03-03 2002-11-12 イーライ リリー アンド カンパニー 薬学的経口ｅｃｂ処方物および組成物の作製方法
EP1156782B1 (de) * 1999-03-03 2005-05-04 Eli Lilly And Company Echinocandin pharmazeutische zusammensetzungen
TWI233805B (en) * 1999-07-01 2005-06-11 Fujisawa Pharmaceutical Co Stabilized pharmaceutical composition in lyophilized form as antifungal agent

Also Published As

Publication number Publication date
US7112565B2 (en) 2006-09-26
EP1107777A1 (de) 2001-06-20
HU229089B1 (en) 2013-07-29
CA2341568C (en) 2011-10-25
EP1107777B1 (de) 2004-10-27
IL141455A (en) 2006-12-31
PL200141B1 (pl) 2008-12-31
BRPI0006823B8 (pt) 2021-05-25
TWI233805B (en) 2005-06-11
NO330353B1 (no) 2011-04-04
ZA200101589B (en) 2002-09-02
CN1179748C (zh) 2004-12-15
CZ20011186A3 (cs) 2001-09-12
US20040157769A1 (en) 2004-08-12
KR20010072903A (ko) 2001-07-31
NZ510290A (en) 2003-07-25
HUP0103740A3 (en) 2002-08-28
CN1636591A (zh) 2005-07-13
CZ295720B6 (cs) 2005-10-12
DE60015279D1 (de) 2004-12-02
ATE280583T1 (de) 2004-11-15
DE60015279T2 (de) 2005-05-25
AU752265B2 (en) 2002-09-12
US6774104B1 (en) 2004-08-10
BRPI0006823B1 (pt) 2020-01-07
TR200100609T1 (tr) 2001-07-23
NO20010893L (no) 2001-04-24
HK1040057A1 (en) 2002-05-24
OA11601A (en) 2004-07-30
CN100352495C (zh) 2007-12-05
JP2003503462A (ja) 2003-01-28
RU2251411C2 (ru) 2005-05-10
JP3381722B2 (ja) 2003-03-04
NO20010893D0 (no) 2001-02-22
AR024634A1 (es) 2002-10-16
BR0006823A (pt) 2001-06-05
AU5572200A (en) 2001-01-22
CN1315865A (zh) 2001-10-03
HUP0103740A2 (hu) 2002-02-28
CA2341568A1 (en) 2001-01-11
WO2001002002A1 (en) 2001-01-11
PT1107777E (pt) 2005-01-31
JP4691866B2 (ja) 2011-06-01
KR100454784B1 (ko) 2004-11-05
HK1080724A1 (en) 2006-05-04
ES2225161T3 (es) 2005-03-16
PL346297A1 (en) 2002-01-28
MXPA01000601A (es) 2002-04-08
JP2002363097A (ja) 2002-12-18
IL141455A0 (en) 2002-03-10
HK1040057B (zh) 2005-08-05

Similar Documents

Publication Publication Date Title
ID29468A (id) Komposisi farmasi yang stabil dalam bentuk liofil
ID28675A (id) Komposisi dosis oral pelepasan diperpanjang yang stabil
FI991485A0 (fi) Uusi farmaseuttinen koostumus
NO20015175L (no) Farmasöytisk sammensetning
ID24915A (id) Komposisi kosmetik yang stabil
ITTO20010008A0 (it) Formulazione farmaceutica
ID24310A (id) Formulasi-formulasi insulin yang stabil
DE69924999D1 (de) Lipasehemmer enthaltende pharmazeutische zusammensetzungen
PT1242087E (pt) Composicoes farmaceuticas
IL147778A0 (en) Pharmaceutical compositions containing cyclobenzaprine
AT7729U3 (de) Pharmazeutische zusammensetzungen enthaltend amlodipinmaleat
NO992339D0 (no) Farmas°ytiske formuleringer
DK1524266T3 (da) Farmaceutisk sammensætning
ID22565A (id) Penggunaan nanodispersi dalam formulasi akhir obat
ITMI991754A0 (it) Composizioni cosmetiche
NO20020086L (no) Smaksmaskerte farmasöytiske flytende formuleringer
HUP0203311A3 (en) New pharmaceutical compositions of prolonged effect
NO20015670L (no) Forbedrede farmasöytiske formuleringer
HUP0301713A3 (en) Pharmaceutical compositions containing propenone derivatives and their use
IS6398A (is) Lyfjablöndur
PT1239832E (pt) Composicoes farmaceuticas
DE10084344T1 (de) Cyclosporin enthaltende pharmazeutische Zusammensetzung
IS6021A (is) Lyfjasamsetningar sem innihalda sítalópram
PT1227817E (pt) Composicao farmaceutica aquosa contendo ciclesonida
FI4488U1 (fi) Farmaseuttinen koostumus